Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125817533 | 12581753 | 3 | F | 201605 | 20160827 | 20160722 | 20160910 | EXP | US-JNJFOC-20160708089 | JOHNSON AND JOHNSON | 72.03 | YR | E | F | Y | 61.24000 | KG | 20160910 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125817533 | 12581753 | 1 | SS | TYLENOL REGULAR STRENGTH | ACETAMINOPHEN | 1 | Oral | Y | U | HPA001 | 0 | TABLET | |||||||
125817533 | 12581753 | 2 | SS | TYLENOL REGULAR STRENGTH | ACETAMINOPHEN | 1 | Oral | 3-4X DAILY | Y | U | HPA001 | 0 | TABLET | ||||||
125817533 | 12581753 | 3 | SS | TYLENOL REGULAR STRENGTH | ACETAMINOPHEN | 1 | Oral | Y | U | HPA001 | 0 | TABLET | |||||||
125817533 | 12581753 | 4 | PS | TYLENOL REGULAR STRENGTH | ACETAMINOPHEN | 1 | Oral | 3-4X DAILY | Y | U | HPA001 | 19872 | TABLET | ||||||
125817533 | 12581753 | 5 | SS | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 1-2 CAPLETS | Y | U | HMA101 | 0 | TABLET | ||||||
125817533 | 12581753 | 6 | SS | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | Y | U | HMA101 | 0 | TABLET | |||||||
125817533 | 12581753 | 7 | SS | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 1-2 CAPLETS | Y | U | HMA101 | 0 | TABLET | ||||||
125817533 | 12581753 | 8 | SS | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | Y | U | HMA101 | 19872 | TABLET | |||||||
125817533 | 12581753 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125817533 | 12581753 | 10 | C | FISH OIL | FISH OIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125817533 | 12581753 | 11 | C | CALCIUM W/VITAMIN D NOS | CALCIUMVITAMIN D | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125817533 | 12581753 | 12 | C | TRI-BUFFERED ASPIRIN | ASPIRIN | 1 | Unknown | 0 | 325 | MG | UNSPECIFIED | ||||||||
125817533 | 12581753 | 13 | C | ANASTROZOLE. | ANASTROZOLE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125817533 | 12581753 | 1 | Arthralgia |
125817533 | 12581753 | 2 | Arthralgia |
125817533 | 12581753 | 3 | Myalgia |
125817533 | 12581753 | 4 | Myalgia |
125817533 | 12581753 | 5 | Arthralgia |
125817533 | 12581753 | 6 | Arthralgia |
125817533 | 12581753 | 7 | Myalgia |
125817533 | 12581753 | 8 | Myalgia |
125817533 | 12581753 | 9 | Routine health maintenance |
125817533 | 12581753 | 10 | Routine health maintenance |
125817533 | 12581753 | 11 | Routine health maintenance |
125817533 | 12581753 | 12 | Product used for unknown indication |
125817533 | 12581753 | 13 | Neoplasm malignant |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125817533 | 12581753 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125817533 | 12581753 | Cerebrovascular accident | |
125817533 | 12581753 | Dehydration | |
125817533 | 12581753 | Drug effect incomplete | |
125817533 | 12581753 | Fluid intake reduced | |
125817533 | 12581753 | Headache | |
125817533 | 12581753 | Incorrect dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125817533 | 12581753 | 2 | 20160517 | 20160630 | 0 | |
125817533 | 12581753 | 4 | 20160517 | 20160630 | 0 | |
125817533 | 12581753 | 5 | 20160630 | 0 | ||
125817533 | 12581753 | 7 | 20160630 | 0 | ||
125817533 | 12581753 | 13 | 20160601 | 0 |